Telsey Advisory Group analyst Dana Telsey reiterates Clear Secure (NYSE:YOU) with a Outperform and maintains $38 price target.
Femasys Inc. Announces Enrollment Completion For Stage 2 Study Of FemBloc For Permanent Birth Control
Femasys Inc. (NASDAQ:FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health,